Karin J. Purdie
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.
RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.
Journal: Frontiers in medicine
Published: February 18, 2026
Is the presence of Merkel cell polyomavirus and human papillomavirus DNA in keratinocyte cancers and precancers associated with HIV status? A case-control study.
Journal: Clinical and experimental dermatology
Published: June 10, 2023
Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression.
Journal: Nature communications
Published: July 26, 2022
The Genomic Landscape of Actinic Keratosis.
Journal: The Journal of investigative dermatology
Published: April 16, 2020
A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.
Journal: International journal of molecular sciences
Published: June 11, 2019
Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
Journal: The Journal of investigative dermatology
Published: May 15, 2018
The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions.
Journal: Frontiers in microbiology
Published: March 19, 2018
Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: August 26, 2016
CREBBP mutation in human cutaneous squamous cell carcinoma.
Journal: Experimental dermatology
Published: April 05, 2016
Last Updated: 09/26/2026